table of content
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics for Infectious Diseases Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics for Infectious Diseases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics for Infectious Diseases Overall Market Size
2.1 Global Molecular Diagnostics for Infectious Diseases Market Size: 2023 VS 2030
2.2 Global Molecular Diagnostics for Infectious Diseases Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Molecular Diagnostics for Infectious Diseases Sales: 2019-2030
3 Company Landscape
3.1 Top Molecular Diagnostics for Infectious Diseases Players in Global Market
3.2 Top Global Molecular Diagnostics for Infectious Diseases Companies Ranked by Revenue
3.3 Global Molecular Diagnostics for Infectious Diseases Revenue by Companies
3.4 Global Molecular Diagnostics for Infectious Diseases Sales by Companies
3.5 Global Molecular Diagnostics for Infectious Diseases Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Molecular Diagnostics for Infectious Diseases Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Molecular Diagnostics for Infectious Diseases Product Type
3.8 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics for Infectious Diseases Players in Global Market
3.8.1 List of Global Tier 1 Molecular Diagnostics for Infectious Diseases Companies
3.8.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics for Infectious Diseases Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnostics for Infectious Diseases Market Size Markets, 2023 & 2030
4.1.2 Respiratory Tract Infections
4.1.3 Reproductive Tract Infections
4.1.4 Blood-borne Infections (BBIs)
4.1.5 Gastrointestinal Infections (GIIs)
4.1.6 Other Infections
4.2 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue, 2019-2024
4.2.2 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue, 2025-2030
4.2.3 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
4.3 By Type - Global Molecular Diagnostics for Infectious Diseases Sales & Forecasts
4.3.1 By Type - Global Molecular Diagnostics for Infectious Diseases Sales, 2019-2024
4.3.2 By Type - Global Molecular Diagnostics for Infectious Diseases Sales, 2025-2030
4.3.3 By Type - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
4.4 By Type - Global Molecular Diagnostics for Infectious Diseases Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics for Infectious Diseases Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Diagnostic Laboratories
5.2 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue, 2019-2024
5.2.2 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue, 2025-2030
5.2.3 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
5.3 By Application - Global Molecular Diagnostics for Infectious Diseases Sales & Forecasts
5.3.1 By Application - Global Molecular Diagnostics for Infectious Diseases Sales, 2019-2024
5.3.2 By Application - Global Molecular Diagnostics for Infectious Diseases Sales, 2025-2030
5.3.3 By Application - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
5.4 By Application - Global Molecular Diagnostics for Infectious Diseases Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics for Infectious Diseases Market Size, 2023 & 2030
6.2 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue, 2019-2024
6.2.2 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue, 2025-2030
6.2.3 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
6.3 By Region - Global Molecular Diagnostics for Infectious Diseases Sales & Forecasts
6.3.1 By Region - Global Molecular Diagnostics for Infectious Diseases Sales, 2019-2024
6.3.2 By Region - Global Molecular Diagnostics for Infectious Diseases Sales, 2025-2030
6.3.3 By Region - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.4.2 By Country - North America Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.4.3 US Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.4.4 Canada Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.4.5 Mexico Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.5.2 By Country - Europe Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.5.3 Germany Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.4 France Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.5 U.K. Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.6 Italy Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.7 Russia Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.8 Nordic Countries Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.9 Benelux Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.6.2 By Region - Asia Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.6.3 China Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.4 Japan Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.5 South Korea Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.6 Southeast Asia Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.7 India Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.7.2 By Country - South America Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.7.3 Brazil Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.7.4 Argentina Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.8.3 Turkey Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8.4 Israel Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8.5 Saudi Arabia Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8.6 UAE Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.1.4 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 Illumina
7.2.1 Illumina Company Summary
7.2.2 Illumina Business Overview
7.2.3 Illumina Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.2.4 Illumina Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.2.5 Illumina Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.3.4 Qiagen Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.3.5 Qiagen Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.4.4 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 BioM?rieux
7.5.1 BioM?rieux Company Summary
7.5.2 BioM?rieux Business Overview
7.5.3 BioM?rieux Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.5.4 BioM?rieux Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.5.5 BioM?rieux Key News & Latest Developments
7.6 Cepheid (Danaher)
7.6.1 Cepheid (Danaher) Company Summary
7.6.2 Cepheid (Danaher) Business Overview
7.6.3 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.6.4 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.6.5 Cepheid (Danaher) Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.7.4 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Hologic
7.8.1 Hologic Company Summary
7.8.2 Hologic Business Overview
7.8.3 Hologic Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.8.4 Hologic Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.8.5 Hologic Key News & Latest Developments
7.9 DiaSorin
7.9.1 DiaSorin Company Summary
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.9.4 DiaSorin Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.9.5 DiaSorin Key News & Latest Developments
7.10 Luminex
7.10.1 Luminex Company Summary
7.10.2 Luminex Business Overview
7.10.3 Luminex Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.10.4 Luminex Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.10.5 Luminex Key News & Latest Developments
7.11 Hoffmann-La Roche
7.11.1 Hoffmann-La Roche Company Summary
7.11.2 Hoffmann-La Roche Business Overview
7.11.3 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.11.4 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.11.5 Hoffmann-La Roche Key News & Latest Developments
7.12 Biocartis
7.12.1 Biocartis Company Summary
7.12.2 Biocartis Business Overview
7.12.3 Biocartis Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.12.4 Biocartis Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.12.5 Biocartis Key News & Latest Developments
7.13 Nanomix
7.13.1 Nanomix Company Summary
7.13.2 Nanomix Business Overview
7.13.3 Nanomix Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.13.4 Nanomix Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.13.5 Nanomix Key News & Latest Developments
7.14 BioFire Diagnostics
7.14.1 BioFire Diagnostics Company Summary
7.14.2 BioFire Diagnostics Business Overview
7.14.3 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.14.4 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.14.5 BioFire Diagnostics Key News & Latest Developments
7.15 Seegene
7.15.1 Seegene Company Summary
7.15.2 Seegene Business Overview
7.15.3 Seegene Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.15.4 Seegene Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.15.5 Seegene Key News & Latest Developments
7.16 QuidelOrtho
7.16.1 QuidelOrtho Company Summary
7.16.2 QuidelOrtho Business Overview
7.16.3 QuidelOrtho Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.16.4 QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.16.5 QuidelOrtho Key News & Latest Developments
7.17 ZeptoMetrix
7.17.1 ZeptoMetrix Company Summary
7.17.2 ZeptoMetrix Business Overview
7.17.3 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.17.4 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.17.5 ZeptoMetrix Key News & Latest Developments
7.18 Sansure
7.18.1 Sansure Company Summary
7.18.2 Sansure Business Overview
7.18.3 Sansure Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.18.4 Sansure Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.18.5 Sansure Key News & Latest Developments
7.19 BGI Genomics
7.19.1 BGI Genomics Company Summary
7.19.2 BGI Genomics Business Overview
7.19.3 BGI Genomics Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.19.4 BGI Genomics Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.19.5 BGI Genomics Key News & Latest Developments
7.20 DaAn Gene
7.20.1 DaAn Gene Company Summary
7.20.2 DaAn Gene Business Overview
7.20.3 DaAn Gene Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.20.4 DaAn Gene Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.20.5 DaAn Gene Key News & Latest Developments
7.21 Kehua Bio-engineering
7.21.1 Kehua Bio-engineering Company Summary
7.21.2 Kehua Bio-engineering Business Overview
7.21.3 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.21.4 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.21.5 Kehua Bio-engineering Key News & Latest Developments
8 Global Molecular Diagnostics for Infectious Diseases Production Capacity, Analysis
8.1 Global Molecular Diagnostics for Infectious Diseases Production Capacity, 2019-2030
8.2 Molecular Diagnostics for Infectious Diseases Production Capacity of Key Manufacturers in Global Market
8.3 Global Molecular Diagnostics for Infectious Diseases Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Molecular Diagnostics for Infectious Diseases Supply Chain Analysis
10.1 Molecular Diagnostics for Infectious Diseases Industry Value Chain
10.2 Molecular Diagnostics for Infectious Diseases Upstream Market
10.3 Molecular Diagnostics for Infectious Diseases Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Molecular Diagnostics for Infectious Diseases Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
